All articles tagged with #geographic atrophy
A new wireless retinal implant called PRIMA shows promise in restoring central vision in patients with advanced age-related macular degeneration (AMD), specifically geographic atrophy, with over 80% of trial participants experiencing meaningful improvements in visual acuity and reading ability after one year, although further research is needed to assess long-term safety and efficacy.
Ocugen, Inc. completes dosing in the first cohort of its Phase 1/2 ArMaDa clinical trial for OCU410, a gene therapy candidate for geographic atrophy (GA), an advanced stage of dry age related macular degeneration (dAMD). The trial aims to assess the safety and efficacy of OCU410, which targets multiple pathways causing dAMD, including complement, lipid metabolism, inflammation, and oxidative stress. The company is optimistic about the potential of OCU410 as a one-time treatment for GA and plans to continue providing clinical updates as the trial progresses.
The FDA has approved Iveric Bio's geographic atrophy treatment, making it the second drug to be cleared for a leading cause of blindness. Iveric Bio will launch the treatment, called Izervay, in the coming weeks at a cost of $2,100 per single-dose vial. This approval strengthens the case for Astellas' recent acquisition of Iveric Bio and follows a previous approval for competitor Apellis.
The recent FDA approval of Syfovre, a new injectable treatment for geographic atrophy, an advanced form of dry age-related macular degeneration, is making it more urgent than ever to address the issue of poor coordination between primary eye care providers and subspecialists. Optometrists and general ophthalmologists will play a critical role in identifying candidates for the new therapy, determining their eligibility, making appropriate referrals to retina specialists, and providing education about potential benefits. To ensure that eye care patients get the seamless care they need quickly and safely, it’s not just providers who need to change. We also need to improve the systems and processes that deliver patient care.